Contact
![Contact Meredith Alda](https://cdn.statcdn.com/contactPerson/3646.jpg)
Mon - Fri, 9am - 6pm (EST)
![Contact Yolanda Mega](https://cdn.statcdn.com/contactPerson/3195.jpg)
Mon - Fri, 9am - 5pm (SGT)
![Contact Kisara Mizuno](https://cdn.statcdn.com/contactPerson/2661.jpg)
Mon - Fri, 10:00am - 6:00pm (JST)
![Contact Lodovica Biagi](https://cdn.statcdn.com/contactPerson/863.jpg)
Mon - Fri, 9:30am - 5pm (GMT)
![Contact Carolina Dulin](https://cdn.statcdn.com/contactPerson/3012.jpg)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in Mauritius has been experiencing steady growth in recent years.
Customer preferences: Mauritius has a growing population with increasing healthcare needs, thus contributing to the growth of the pharmaceuticals market. Customers in Mauritius are becoming more health-conscious and are seeking better quality products. They are also looking for affordable healthcare solutions, which has led to an increase in demand for generic drugs.
Trends in the market: The pharmaceuticals market in Mauritius is dominated by imported drugs, with India being the largest supplier. The market is highly competitive, with many local and international players. There is a growing trend towards the use of herbal and natural remedies, which has led to an increase in demand for traditional medicines. Moreover, there has been a shift towards the use of e-pharmacies, which has made it easier for customers to access medicines.
Local special circumstances: The government of Mauritius has been taking steps to improve healthcare in the country, which has led to an increase in demand for pharmaceuticals. The government has been investing in healthcare infrastructure and has been working towards improving access to healthcare for all citizens. Additionally, the country has a well-established regulatory framework for the pharmaceuticals industry, which ensures that only safe and effective drugs are available in the market.
Underlying macroeconomic factors: Mauritius has a stable political environment and a well-diversified economy, which has contributed to the growth of the pharmaceuticals market. The country has a strong focus on education and has a well-educated workforce, which has led to the development of a skilled pharmaceuticals industry. Furthermore, Mauritius is strategically located, making it an ideal hub for pharmaceutical companies looking to expand into the African market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)